Genetic requirements for executing SUMO stress signals and achieving stress tolerance

执行 SUMO 应激信号和实现应激耐受性的遗传要求

基本信息

  • 批准号:
    10514836
  • 负责人:
  • 金额:
    $ 43.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Temperature, radiation, oxidizing reagents, as well as shear and osmotic stress are environmental, extrinsic stressors that cause tissue and cellular damage. There is good evidence that organisms as diverse as yeast and humans utilize SUMO modification as part of their cellular stress response. SUMO is a small proteinaceous modifier that can be covalently linked to specific target proteins, affecting their activity, localization, interactions, and half-life. This project focuses on the SUMO Stress Response (SSR), the rapid increase of protein sumoylation after cells experience acute proteotoxic stress. The SSR is believed to play a cyto- protective role for normal cells, but it may also enhances the robustness of cancerous cells and some eukaryotic pathogens. Stress-induced sumoylation has profound effects on transcriptional reprogramming and protein complex integrity in the nucleus. However, there is little or no knowledge how the SSR affects cytoplasmic processes including cytoskeletal rearrangements, mitochondrial inheritance, vesicle sorting, and translation. Here we use the genetically tractable yeast Sacharomyces cerevisiae to address our hypothesis that cross-talk between protein sumoylation and ubiquitination in the cytoplasm plays a central role in cytoprotective effects initiated by dynamic stress-induced sumoylation. The specific aims of this project are 1) to use cell biological and genetic approaches, and an innovative yeast SUMO Stress Reporter strain, to dissect the choreography of the SSR. Specifically, to investigate evidence of stress-induced cooperativity of the SUMO E3 ligase Siz1 and the NEDD4/Rsp5 E3 ubiquitin ligase in the cytoplasm that may exert stress-induced control over cytoskeleton organization, mitochondrial inheritance, vesicle sorting, and translation. 2) To analyze a group of potential cytoplasmic SSR effector proteins we identified and to examine the functional consequences of genetic defects that result in their dysfunction. 3) To use innovative methods to identify variant SUMO pathway components that promote stress tolerance with the goal to ultimately test clinically-relevant alleles of SUMO pathway genes that may affect stress tolerance and the likelihood of cancer development. Our project is well-aligned with AREA program goals and will expose undergraduate students to meritorious research that is biomedically relevant.
项目概要/摘要: 温度,辐射,氧化剂,以及剪切和渗透应力, 导致组织和细胞损伤的环境、外在应激因素。有好 有证据表明,酵母和人类等多种生物利用SUMO修饰作为 细胞应激反应SUMO是一种小的蛋白质修饰剂,可以共价结合 与特定的靶蛋白相关联,影响其活性、定位、相互作用和半衰期。 本项目主要研究SUMO应激反应(SSR),即蛋白质的快速增加, 细胞经历急性蛋白毒性应激后的类小泛素化。战略科学军团被认为是... 对正常细胞有保护作用,但它也可能增强癌细胞的鲁棒性, 一些真核生物病原体应激诱导的类小泛素化对转录水平有着深刻的影响, 重编程和蛋白质复合物的完整性。然而,很少或没有 了解SSR如何影响细胞质过程,包括细胞骨架重排, 线粒体遗传、囊泡分选和翻译。在这里,我们使用遗传上易于处理的 酵母酿酒酵母,以解决我们假设,蛋白质之间的串扰 细胞质中的SUMO化和泛素化在细胞保护作用中起核心作用 由动态应激诱导的类小泛素化引发。该项目的具体目标是:1)使用 细胞生物学和遗传学方法,以及创新的酵母SUMO压力报告菌株, 剖析战略科学军团的舞蹈编排具体来说,为了调查压力引起的 SUMO E3连接酶Siz 1和NEDD 4/Rsp 5 E3泛素连接酶在细胞中的协同性 细胞质,可能发挥压力诱导的控制细胞骨架组织,线粒体 遗传、囊泡分选和翻译。2)分析一组潜在的细胞质SSR标记 我们确定的效应蛋白,并检查遗传缺陷的功能后果, 导致他们功能障碍。3)使用创新方法鉴定变异SUMO通路 促进压力耐受性的成分,目的是最终测试临床相关的 SUMO途径基因的等位基因可能影响应激耐受性和癌症的可能性 发展我们的项目与区域计划目标保持一致,并将暴露 本科生值得研究,是生物医学相关的。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Protein Modification Employing Non-Canonical Amino Acids to Prepare SUMOylation Detecting Bioconjugates.
  • DOI:
    10.3390/pharmaceutics14122826
  • 发表时间:
    2022-12-16
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Williard AC;Switzer HJ;Howard CA;Yin R;Russell BL;Sanyal R;Yu S;Myers TM;Flood BM;Kerscher O;Young DD
  • 通讯作者:
    Young DD
Chemical Genetics Screen of EVP4593 Sensitivity in Budding Yeast Identifies Effects on Mitochondrial Structure and Function.
  • DOI:
    10.17912/micropub.biology.000806
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiestand, Lexie;Shen, Stella;Sloan, Willough;Nasiri, Hamid;Lashley, Dana;Kerscher, Oliver
  • 通讯作者:
    Kerscher, Oliver
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oliver none Kerscher其他文献

Oliver none Kerscher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oliver none Kerscher', 18)}}的其他基金

Role of the SUMO Protease Ulp1 in Cell Cycle Progression
SUMO 蛋白酶 Ulp1 在细胞周期进展中的作用
  • 批准号:
    8005172
  • 财政年份:
    2010
  • 资助金额:
    $ 43.64万
  • 项目类别:
Role of the SUMO Protease Ulp1 in Cell Cycle Progression
SUMO 蛋白酶 Ulp1 在细胞周期进展中的作用
  • 批准号:
    7515830
  • 财政年份:
    2008
  • 资助金额:
    $ 43.64万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 43.64万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了